TGA-2023-0087-V287

Type IA variation for application TGA-2023-0087. Type IA variation: New Dosage Strength for Thymosilib — critical change

Variation Number
TGA-2023-0087-V287
Type
Type IA
Application
TGA-2023-0087
Change
CHG-2022-0287
Status
Overdue
Fee
€1,538
Submitted
2023-05-21
Approved
—
Description

Type IA variation: New Dosage Strength for Thymosilib — critical change